Stay updated on Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial
Sign up to get notified when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.

Latest updates to the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page
- ChecktodayChange DetectedAdded recruitment-status notice and new help sections (How to Read a Study Record, Common Questions, How to Join a Study). Updated the Intervention/Treatment header formatting and revision tag to v3.6.0.SummaryDifference0.3%

- Check8 days agoChange DetectedRevision v3.5.5 was introduced, replacing the previous v3.5.4. This appears to be an administrative update to the page and does not reflect substantive changes to the study details.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4, indicating a minor update to the page metadata without altering the study details.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page’s site footer version was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a general platform release without changing the study record content.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page now lists 44 locations for the study; the detailed site list has been trimmed. Revision: v3.5.0 is displayed on the page.SummaryDifference4%

Stay in the know with updates to Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.